Maravai Lifesciences Holdings (MRVI) Free Cash Flow Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 88.70% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.72% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 66.37% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 743.11 Mn | 734.71 Mn | 33.70 Mn | 139.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.06% |
| Dec 31, 2025 | -70.84% |
| Sep 30, 2025 | -415.60% |
| Jun 30, 2025 | -296.23% |
| Mar 31, 2025 | 6.92% |
| Dec 31, 2024 | -127.41% |
| Sep 30, 2024 | 114.28% |
| Jun 30, 2024 | -77.87% |
| Mar 31, 2024 | -115.06% |
| Dec 31, 2023 | -110.72% |
| Sep 30, 2023 | -128.25% |
| Jun 30, 2023 | -85.06% |
| Mar 31, 2023 | -51.61% |
| Dec 31, 2022 | 46.27% |
| Sep 30, 2022 | 0.10% |
| Jun 30, 2022 | 0.75% |
| Mar 31, 2022 | 355.95% |
| Dec 31, 2021 | -30.44% |
| Sep 30, 2021 | 113.45% |
| Jun 30, 2021 | 1,786.47% |